1. Signaling Pathways
  2. NF-κB
  3. NF-κB

NF-κB (核因子κB)

Nuclear factor-κB; Nuclear factor-kappaB

NF-κB(活化 B 细胞的核因子 κ 轻链增强子)是一种控制 DNA 转录的蛋白质复合物。NF-κB 存在于几乎所有动物细胞类型中,并参与细胞对压力、细胞因子、自由基、紫外线照射、氧化 LDL 以及细菌或病毒抗原等刺激的反应。NF-κB 在调节对感染的免疫反应中起着关键作用。NF-κB 的错误调节与癌症、炎症和自身免疫性疾病、感染性休克、病毒感染和免疫发育不当有关。NF-κB 还与突触可塑性和记忆过程有关。哺乳动物 NF-κB 家族中有五种蛋白质:NF-κB1、NF-κB2、RelA、RelB、c-Rel。

NF-κB (Nuclear factor kappa-light-chain-enhancer of activated B cells) is a protein complex that controls transcription of DNA. NF-κB is found in almost all animal cell types and is involved in cellular responses to stimuli such as stress, cytokines, free radicals, ultraviolet irradiation, oxidized LDL, and bacterial or viral antigens. NF-κB plays a key role in regulating the immune response to infection. Incorrect regulation of NF-κB has been linked to cancer, inflammatory, and autoimmune diseases, septic shock, viral infection, and improper immune development. NF-κB has also been implicated in processes of synaptic plasticity and memory. There are five proteins in the mammalian NF-κB family: NF-κB1, NF-κB2, RelA, RelB, c-Rel.

Cat. No. Product Name Effect Purity Chemical Structure
  • HY-B1640R
    Ethacrynic acid (Standard) Inhibitor
    Ethacrynic acid (Standard) 是 Ethacrynic acid 的分析标准品。本产品用于研究及分析应用。Ethacrynic acid (Etacrynic acid) 是一种利尿剂。Ethacrynic acid 是谷胱甘肽 S-转移酶 (GSTs) 的抑制剂。Ethacrynic acid 是一种 NF-κB 信号传导途径的有效抑制剂,并且还调节白三烯的形成。Ethacrynic acid 还可抑制 L 型电压依赖性和储存操作的钙通道,从而导致气道平滑肌细胞松弛。Ethacrynic acid 具有抗炎特性,可减轻类维生素 A 诱导的小鼠耳部水肿。
    Ethacrynic acid (Standard)
  • HY-124651
    SEMBL Inhibitor 99.16%
    SEMBL 是一种有效的 NF-κB 抑制剂。SEMBL 能够抑制 NF-κB-DNA 结合,还抑制 NF-κB 依赖性炎性细胞因子分泌。SEMBL 通过降低 MMP 表达来抑制癌细胞的迁移和侵袭。可用于抗癌研究。
    SEMBL
  • HY-N0081
    (±)-Praeruptorin A

    (±)-白花前胡甲素

    Inhibitor 99.94%
    (±)-Praeruptorin A 是一种香豆素化合物,是 Peucedani Radix 中主要的生物活性成分。(±)-Praeruptorin A 作为钙通道阻滞剂表现出极大的抗高血压效应。此外,(±)-Praeruptorin A 还具有松弛血管平滑肌、抑制气道炎症和气道高反应性的作用。(±)-Praeruptorin A 可用于过敏性哮喘和高血压等疾病的研究。
    (±)-Praeruptorin A
  • HY-N2157
    Pteryxin

    北美芹素

    Inhibitor 99.96%
    Pteryxin ((+)-Pteryxin) 是一种口服有效的多靶点抑制,靶向 NF-κBMAPKNLRP3 炎症小体及 Nrf2/ARE 通路等。Pteryxin 还是 BChE 抑制剂 (IC50=12.96 μg/mL),对 AChE 的抑制效率较低。Pteryxin 通过阻断 NF-κB/MAPK 信号传导、抑制 NLRP3 炎症小体激活、减少 ROS 生成以抑制 Ca2+-钙调神经磷酸酶-NFATc1 通路,并激活 Nrf2 介导的抗氧化酶表达。Pteryxin 具有抗炎、抗氧化和抑制破骨细胞生成等活性。Pteryxin 可用于炎症性疾病、骨质疏松、糖尿病和阿尔茨海默病等领域的研究。
    Pteryxin
  • HY-148552
    Anti-inflammatory agent 35 Inhibitor 99.77%
    Anti-inflammatory agent 35 (化合物 5a27) 是一种口服有效的姜黄素类似物,具有抗炎活性。Anti-inflammatory agent 35 可阻断丝裂原活化蛋白激酶 (MAPK) 信号和 NF-kB 的核易位。Anti-inflammatory agent 35 还抑制黄中性粒细胞浸润和促炎细胞因子产生。Anti-inflammatory agent 35 在体内研究中显著减轻脂多糖 (LPS) 诱导的急性肺损伤 (ALI)。
    Anti-inflammatory agent 35
  • HY-Y1322
    Triphenyl phosphate

    磷酸三苯基酯

    Activator 99.67%
    Triphenyl phosphate 是一种有机磷酸盐阻燃剂。Triphenyl phosphate 可通过激活 MAOA/ROS/NFκB 破坏胎盘色氨酸代谢,诱发异常的神经行为。Triphenyl phosphate 促进核因子 κ B (NFκB)、白细胞介素-6肿瘤坏死因子α 等炎症因子诱导氧化应激。Triphenyl phosphate 可引起过敏性接触性皮炎。
    Triphenyl phosphate
  • HY-117987
    CPS-11 Inhibitor 99.39%
    CPS-11 (N-(Hydroxymethyl)thalidomide) 是 Thalidomide (HY-14658) 类似物,是一种有效的抗癌剂 (anti-cancer agent)。CPS-11 可抑制 NF-κB,激活 NFAT,通过升高 ROS 抑制细胞因子表达。CPS-11 对 MM (多发性骨髓瘤)细胞系表现出更广泛的活性谱和更高的效力。
    CPS-11
  • HY-Y0586
    2,4,5-Trimethoxybenzoic acid Inhibitor 99.98%
    2,4,5-Trimethoxybenzoic acid (Asaronic acid) 是紫苏提取物中的一种化合物。2,4,5-Trimethoxybenzoic acid 抑制 LPS (HY-D1056) 诱导的炎症反应,抑制 NF-κBSTAT 信号通路的激活。2,4,5-Trimethoxybenzoic acid 抑制 M1 巨噬细胞表型介导的糖尿病炎症。
    2,4,5-Trimethoxybenzoic acid
  • HY-N4231
    Lucyoside B Inhibitor 99.21%
    Lucyoside B 在活化的巨噬细胞中通过 NF-κB 和激活因子蛋白-1途径抑制炎症介质的产生。
    Lucyoside B
  • HY-134353B
    ADP-β-S trilithium Activator
    ADP-β-S trilithium 是 ADP-β-S (HY-134353) 的三锂盐形式。ADP-β-S trilithium 是 P2Y12 受体的激活剂,可上调小胶质细胞中的 IL-1β 和 IL-6 产生水平,促进 NF-κB 的磷酸化和核转位,并增强 NLRP3 炎症小体的活化。
    ADP-β-S trilithium
  • HY-126818
    Desfuroylceftiofur Inhibitor
    Desfuroylceftiofur 是 Ceftiofur 的活性代谢物,Ceftiofur 是一种广谱头孢菌素抗生素。Desfuroylceftiofur 对革兰氏阳性菌和革兰氏阴性菌有抗菌活性。
    Desfuroylceftiofur
  • HY-W011398
    Linoleate sodium

    顺,顺-9,12-十八碳二烯酸钠盐

    99.88%
    Linoleate sodium 是一个口服活性的和 JNKNF-κB 通路介导的 IL8 调节剂。Linoleate sodium 可以改变细胞中脂肪酸的组成和代谢物的产生。Linoleate sodium 具有抗炎、免疫调节和影响肿瘤细胞生长的活性。
    Linoleate sodium
  • HY-N1913A
    Danshensu sodium

    丹参素钠盐

    Inhibitor 99.9%
    Danshensu (Dan shen suan A) sodium 是一种具有口服活性的酚类化合物,可诱导 Nrf2/HO-1 激活并抑制 NF-κB 通路。Danshensu sodium 可减少活性氧 (ROS) 的产生,上调抗氧化防御机制并抑制内在的细胞凋亡途径。Danshensu sodium 对 SARS-CoV-2 显示出有效的抗病毒活性,EC50 为 0.97 μM。Danshensu sodium 具有抗氧化、抗凋亡、抗肺部炎症等作用,具有用于 COVID-19、心脑血管等疾病研究的潜力。
    Danshensu sodium
  • HY-P99635
    Gatralimab

    格曲利单抗

    Inhibitor 99.90%
    Gatralimab (GZ-402668) 是一种 IgG1CD52 单克隆抗体。
    Gatralimab
  • HY-N2205
    Esculentoside H Inhibitor 98.73%
    Esculentoside H (EsH) 是从多年生植物 Phytolacca esculent 的根提取物中分离的一种皂苷。 Esculentoside H (EH) 具有抗肿瘤活性,其机制与 TNF 释放能力有关。 Esculentoside H (EsH) 通过阻断 JNK1/2 和 NF-κB 信号介导的基质金属蛋白酶-9 (MMP-9) 表达抑制结肠癌细胞迁移。
    Esculentoside H
  • HY-B0516
    Articaine hydrochloride

    盐酸阿替卡因

    Inhibitor 99.38%
    Articaine (Hoe-045) hydrochloride 是一种电压门控钠离子通道 (如 rNav1.4hNav1.7rNav1.8) 的选择性抑制剂,对开放态 Na+ 通道的 IC50 为 15.8 μM;而对失活态和静息态 Na+ 通道的 IC50 分别为 40.6 μM 和 378 μM。Articaine hydrochloride 通过抑制 Na+ 内流阻断神经冲动传导,发挥局部麻醉活性,同时可抑制 NF-κB 激活及 NLRP3 炎症小体通路,展现抗炎功能。Articaine hydrochloride 可用于牙科局部麻醉、炎症相关疾病 (如急性肾损伤) 的研究。
    Articaine hydrochloride
  • HY-157793
    SMU-L11 Activator 99.64%
    SMU-L11 是一种特异性 TLR7 激动剂 (EC50=0.024 μM),可招募 MyD88 接头蛋白并激活下游 NF-κBMAPK 信号通路。SMU-L11 在小鼠模型中,显著增强免疫细胞活化并增强 CD4+ T 和 CD8+ T 细胞增殖,从而直接杀死肿瘤细胞并抑制肿瘤生长。SMU-L11 可用于癌症的研究,也有研究免疫系统疾病的潜力。
    SMU-L11
  • HY-N2303
    Eriocalyxin B Inhibitor 99.93%
    Eriocalyxin B 是一种可以从中草药毛萼香茶菜中分离得到的二萜类化合物。Eriocalyxin B 具有抗癌、抗炎和抑制脂肪生成等多种活性。Eriocalyxin B 能够诱导肿瘤细胞凋亡 (apoptosis) 和自噬 (autophagy)。Eriocalyxin B 可用于癌症和自身免疫性疾病等的研究。
    Eriocalyxin B
  • HY-P10030
    DPLG3 Inhibitor 99.18%
    DPLG3 DPLG3是一种特异性免疫蛋白酶体 β5i 亚基抑制剂,IC50 为 4.5 nM。DPLG3 抑制小鼠 i-20S, IC50值为 9.4 nM。DPLG3 下调 NF-κB p50p65 的蛋白水平。DPLG3 可用于免疫疾病的研究。
    DPLG3
  • HY-N0197R
    Baicalin (Standard)

    黄芩苷 (Standard)

    Inhibitor
    Baicalin (Standard) 是 Baicalin 的分析标准品。本产品用于研究及分析应用。Baicalin 作为一种类黄酮糖苷,是一种变构肉碱棕榈酰转移酶1 (CPT1)是激活剂。Baicalin 降低 NF-κB 表达。
    Baicalin (Standard)
目录号 产品名 / 同用名 应用 反应物种

NF-κB transcription factors are critical regulators of immunity, stress responses, apoptosis and differentiation. In mammals, there are five members of the transcription factor NF-κB family: RELA (p65), RELB and c-REL, and the precursor proteins NF-κB1 (p105) and NF-κB2 (p100), which are processed into p50 and p52, respectively. NF-κB transcription factors bind as dimers to κB sites in promoters and enhancers of a variety of genes and induce or repress transcription. NF-κB activation occurs via two major signaling pathways: the canonical and the non-canonical NF-κB signaling pathways[1]

 

The canonical NF-κB pathway is triggered by signals from a large variety of immune receptors, such as TNFR, TLR, and IL-1R, which activate TAK1. TAK1 then activates IκB kinase (IKK) complex, composed of catalytic (IKKα and IKKβ) and regulatory (NEMO) subunits, via phosphorylation of IKKβ. Upon stimulation, the IKK complex, largely through IKKβ, phosphorylates members of the inhibitor of κB (IκB) family, such as IκBα and the IκB-like molecule p105, which sequester NF-κB members in the cytoplasm. IκBα associates with dimers of p50 and members of the REL family (RELA or c-REL), whereas p105 associates with p50 or REL (RELA or c-REL). Upon phosphorylation by IKK, IκBα and p105 are degradated in the proteasome, resulting in the nuclear translocation of canonical NF-κB family members, which bind to specific DNA elements, in the form of various dimeric complexes, including RELA-p50, c-REL-p50, and p50-p50. Atypical, IKK-independent pathways of NF-κB induction also provide mechanisms to integrate parallel signaling pathways to increase NF-κB activity, such as hypoxia, UV and genotoxic stress.

 

The non-canonical NF-κB pathway is induced by certain TNF superfamily members, such as CD40L, BAFF and lymphotoxin-β (LT-β), which stimulates the recruitment of TRAF2, TRAF3, cIAP1/2 to the receptor complex. Activated cIAP mediates K48 ubiquitylation and proteasomal degradation of TRAF3, resulting in stabilization and accumulation of the NFκB-inducing kinase (NIK). NIK phosphorylates and activates IKKα, which in turn phosphorylates p100, triggering p100 processing, and leading to the generation of p52 and the nuclear translocation of p52 and RELB[2][3].

 

Reference:

[1]. Oeckinghaus A, et al. The NF-kappaB family of transcription factors and its regulation.Cold Spring Harb Perspect Biol. 2009 Oct;1(4):a000034. 
[2]. Taniguchi K, et al. NF-κB, inflammation, immunity and cancer: coming of age. Nat Rev Immunol. 2018 May;18(5):309-324.
[3]. Perkins ND,et al. Integrating cell-signalling pathways with NF-kappaB and IKK function. Nat Rev Mol Cell Biol. 2007 Jan;8(1):49-62.

Your Search Returned No Results.

Sorry. There is currently no product that acts on isoform together.

Please try each isoform separately.